Regulations.gov document
Reference 2 Guidance for Industry Gene Therapy Clinical Trials Observing Subjects for…
Supporting & Related Material · FDA-2015-D-3399 · posted Oct 15, 2015
Key facts
| Document ID | FDA-2015-D-3399-0005 |
|---|---|
| Title | Reference 2 Guidance for Industry Gene Therapy Clinical Trials Observing Subjects for Delayed Adverse Events 2006 re Recommendations for Microbial Vectors used for Gene Therapy Draft Guidance for Industry |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2015-D-3399 |
| Posted | Oct 15, 2015 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: